Carmell Therapeutics (Pittsburgh, PA) a development-stage biopharmaceutical company focused on biomaterials for connective tissue repair, closed a $2.4M Series A financing. Participants include Harbor Light Capital Partners, Newlin Investment Company, PLSG Accelerator Fund, Innovation Works, Ariel Savannah Angels and Blue Tree Allied Angels.